| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pharmacology and Therapeutics, State University of New York School of Medicine and Biomedical Sciences Buffalo, New York 14214
Address all correspondence and requests for reprints to: Dr. Laychock, 102 Farber Hall, Department of Pharmacology and Therapeutics, State University of New York School of Medicine, Buffalo, New York 14214.
Abstract
L-Arginine (L-Arg) is metabolized by nitric oxide synthase to the reactive intermediate nitric oxide. Since nitric oxide stimulates guanylyl cyclase and cGMP synthesis, LArg effects on cGMP accumulation in isolated pancreatic islets of the rat and RINm5F insulinoma cells were determined. Both L-Arg and glucose stimulation increased islet cGMP levels, and glucose potentiated the response to L-Arg alone. A competitive inhibitor of L-Arg metabolism to nitric oxide,NG-monomethyl- L-arginine, reduced glucose- and L-Arg-stimulated insulin release and glucose-induced increases in cGMP; however, basal insulin release was slightly increased. D-Arg and L-ornithine did not affect islet cGMP levels, although insulin release was stimulated. RINm5F cell cGMP levels and insulin release increased in response to L-Arg in a concentration- and time-related manner, whereas glucose and L-histidine were without effect. 8- Bromo-cGMP also slightly increased RINm5F cell insulin release. Sodium nitroprusside as a source of nitric oxide increased RINm5F cell cGMP production. Methylene blue and LY83583, inhibitors of soluble guanylyl cyclase activation, reduced RINm5F cell cGMP levels in the presence and absence of L-Arg; LY83583 also reduced glucose-stimulated cGMP levels in islets. Insulin release by glucose and L-Arg was also inhibited by methylene blue and LY83583 in islets. We conclude that glucose and L-Arg stimulate guanylyl cyclase activity and cGMP formation in β-cells at least in part through metabolism to the reactive intermediate nitric oxide. However, neither nitric oxide nor cGMP synthesis is obligatory for insulin secretion. (Endocrinology 129: 3043–3052, 1991)
Footnotes
* This work was supported by NIH Grant AM-25705.
Received May 13, 1991.
This article has been cited by other articles:
![]() |
C. S. Nunemaker, D. G. Buerk, M. Zhang, and L. S. Satin Glucose-induced release of nitric oxide from mouse pancreatic islets as detected with nitric oxide-selective glass microelectrodes Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E907 - E912. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mosen, A. Salehi, P. Alm, R. Henningsson, J. Jimenez-Feltstrom, C.-G. Ostenson, S. Efendic, and I. Lundquist Defective Glucose-Stimulated Insulin Release in the Diabetic Goto-Kakizaki (GK) Rat Coincides with Reduced Activity of the Islet Carbon Monoxide Signaling Pathway Endocrinology, March 1, 2005; 146(3): 1553 - 1558. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Soria, I. Quesada, A. B. Ropero, J. A. Pertusa, F. Martin, and A. Nadal Novel Players in Pancreatic Islet Signaling: From Membrane Receptors to Nuclear Channels Diabetes, February 1, 2004; 53(90001): S86 - 91. [Abstract] [Full Text] |
||||
![]() |
Y. Kaneko, T. Ishikawa, S. Amano, and K. Nakayama Dual effect of nitric oxide on cytosolic Ca2+ concentration and insulin secretion in rat pancreatic beta -cells Am J Physiol Cell Physiol, May 1, 2003; 284(5): C1215 - C1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Smukler, L. Tang, M. B. Wheeler, and A. M. F. Salapatek Exogenous Nitric Oxide and Endogenous Glucose-Stimulated {beta}-Cell Nitric Oxide Augment Insulin Release Diabetes, December 1, 2002; 51(12): 3450 - 3460. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Henningsson, A. Salehi, and I. Lundquist Role of nitric oxide synthase isoforms in glucose-stimulated insulin release Am J Physiol Cell Physiol, July 1, 2002; 283(1): C296 - C304. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brissova, M. Shiota, W. E. Nicholson, M. Gannon, S. M. Knobel, D. W. Piston, C. V. E. Wright, and A. C. Powers Reduction in Pancreatic Transcription Factor PDX-1 Impairs Glucose-stimulated Insulin Secretion J. Biol. Chem., March 22, 2002; 277(13): 11225 - 11232. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Henningsson, P. Alm, and I. Lundquist Evaluation of islet heme oxygenase-CO and nitric oxide synthase-NO pathways during acute endotoxemia Am J Physiol Cell Physiol, May 1, 2001; 280(5): C1242 - C1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Henningsson, P. Alm, E. Lindstrom, and I. Lundquist Chronic blockade of NO synthase paradoxically increases islet NO production and modulates islet hormone release Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E95 - E107. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B Ropero, E. Fuentes, J. M Rovira, C. Ripoll, B. Soria, and A. Nadal Non-genomic actions of 17{beta}-oestradiol in mouse pancreatic {beta}-cells are mediated by a cGMP-dependent protein kinase J. Physiol., December 1, 1999; 521(2): 397 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Spinas The Dual Role of Nitric Oxide in Islet beta-Cells Physiology, April 1, 1999; 14(2): 49 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Akesson and I. Lundquist Influence of nitric oxide modulators on cholinergically stimulated hormone release from mouse islets J. Physiol., March 1, 1999; 515(2): 463 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yang, B. Lee, T.-H. Chen, and W. H. Hsu Mechanisms of Bradykinin-Induced Insulin Secretion in Clonal beta Cell Line RINm5F J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1247 - 1252. [Abstract] [Full Text] |
||||
![]() |
H. Schmidt, T. Warner, K Ishii, H Sheng, and F Murad Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides Science, February 7, 1992; 255(5045): 721 - 723. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |